Related Experiment Video
Updated: Feb 25, 2026

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
Management and Prevention of Saphenous Vein Graft Failure: A Review
Peter McKavanagh1, Bobby Yanagawa2, George Zawadowski2
1Terrence Donnelly Heart Center, Divisions of Cardiology and Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada. mckavanagh@doctors.net.uk.
Insights
Coronary artery bypass grafting (CABG) using saphenous vein grafts (SVG) is crucial for multivessel coronary artery disease (CAD). This review details SVG failure, its causes, and prevention strategies to improve long-term patient outcomes.
Area of Science:
- Cardiology
- Vascular Surgery
- Biomedical Engineering
Background:
- Coronary artery bypass grafting (CABG) is essential for multivessel coronary artery disease (CAD), particularly in diabetic patients.
- Internal thoracic artery grafts offer superior long-term patency and are the gold standard for severe CAD revascularization.
- Saphenous vein grafts (SVG) are frequently used for complete revascularization but exhibit limited longevity and are linked to adverse cardiac events.
Purpose of the Study:
- To review the pathogenesis of saphenous vein graft (SVG) failure in coronary artery bypass grafting (CABG).
- To differentiate between early, intermediate, and late phases of SVG failure.
- To explore surgical techniques, medical management, and percutaneous interventions impacting SVG failure.
Main Methods:
- Literature review of studies on SVG failure in CABG.
- Analysis of factors contributing to early, intermediate, and late graft occlusion.
- Examination of current prevention and treatment strategies for SVG failure.
Main Results:
- SVG failure is multifactorial, influenced by intrinsic graft properties and surgical technique.
- Early failure is often due to technical issues, while late failure involves atherosclerosis and intimal hyperplasia.
- Medical and interventional therapies show promise in mitigating SVG failure.
Conclusions:
- Understanding SVG failure mechanisms is critical for improving CABG outcomes.
- Optimizing surgical techniques and employing contemporary medical/interventional strategies can enhance graft patency.
- Further research is needed to refine prevention and treatment of SVG failure for long-term cardiac health.
Abstract:
Coronary artery bypass grafting (CABG) remains a vital treatment for patients with multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the internal thoracic artery graft is well established and remains the gold standard for revascularization of severe CAD. It is not always possible to achieve complete revascularization through arterial grafts, necessitating the use of saphenous vein grafts (SVG). Unfortunately, SVGs do not have the same longevity, and their failure is associated with significant adverse cardiac outcomes and mortality. This paper reviews the pathogenesis of SVG failure, highlighting the difference between early, intermediate, and late failure. It also addresses the different surgical techniques that affect the incidence of SVG failure, as well as the medical and percutaneous prevention and treatment options in contemporary practice.
More Related Videos
09:50Procedure for Human Saphenous Veins Ex Vivo Perfusion and External Reinforcement
Published on: October 1, 2014
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction